Predicted protein targets (top 11)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MAOB | P27338 | 5/20 | 0.37 |
| ▸ | MAOA | P21397 | 4/20 | 0.37 |
| ▸ | ALOX5AP | P20292 | 4/20 | 0.34 |
| ▸ | S1PR1 | P21453 | 8/20 | 0.34 |
| ▸ | S1PR3 | Q99500 | 1/20 | 0.34 |
| ▸ | PPARD | Q03181 | 1/20 | 0.33 |
| ▸ | PPARA | Q07869 | 1/20 | 0.33 |
| ▸ | FEN1 | P39748 | 2/20 | 0.32 |
| ▸ | GPR84 | Q9NQS5 | 2/20 | 0.32 |
| ▸ | S1PR4 | O95977 | 1/20 | 0.32 |
| ▸ | S1PR5 | Q9H228 | 1/20 | 0.32 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL31435363 | 1.00 | MAOB (0.37) | MAOBMAOAALOX5APS1PR1S1PR3 | |
| SCHEMBL31435295 | 0.81 | S1PR1 (0.58) | S1PR1S1PR3S1PR4S1PR5 | |
| SCHEMBL31435341 | 0.72 | S1PR1 (0.45) | MAOBMAOAS1PR1S1PR3S1PR4 | |
| SCHEMBL1874151 | 0.71 | SRD5A1 (0.55) | MAOBMAOAS1PR1 | |
| SCHEMBL450942 | 0.70 | MAOB (0.56) | MAOBMAOAS1PR1 | |
| SCHEMBL10088965 | 0.68 | S1PR1 (0.49) | MAOBMAOAS1PR1S1PR3S1PR4 | |
| SCHEMBL19432985 | 0.67 | DRD2 (0.39) | MAOB | |
| SCHEMBL10310545 | 0.67 | MAOA (0.36) | MAOBMAOAS1PR1S1PR3PPARD | |
| SCHEMBL10088588 | 0.67 | SRD5A1 (0.42) | MAOBMAOAS1PR1S1PR3 | |
| SCHEMBL316466 | 0.66 | CYP26A1 (0.48) | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2025090792-A1 | AMIDE PRODRUGS AND USES THEREOF | AUTOBAHN THERAPEUTICS, INC. (US) | 2025-05-01 | — | — | WO | disclosed |